According to our (Global Info Research) latest study, the global C3F8 Ophthalmic Gas market size was valued at US$ 84.37 million in 2025 and is forecast to a readjusted size of US$ 119 million by 2032 with a CAGR of 5.1% during review period.
C3F8 (Perfluoropropane/Octafluoropropane) is a long-acting, medically inert gas used in retinal surgery. Surgeons inject it into the eye to create a temporary bubble that presses against the retina, holding it in place so complex tears or detachments can heal.
In 2025, global production of C3F8 Ophthalmic Gas reached 162 k units, with an average selling price of USD 507 per unit and total production capacity of approximately 200,000 bottles. The industry's gross margin was around 40%–70%. In terms of cost structure, direct materials accounted for about 60%, manufacturing overhead for about 34%, and labor costs for about 6%. The industry chain consists of high-purity perfluoropropane (C3F8) raw gas, medical-grade gas purification and testing, sterile filling packaging materials, gas-tight containers, and other upstream inputs, while downstream demand mainly comes from ophthalmic hospitals, ophthalmology departments of general hospitals, ophthalmic specialty chain institutions, and similar end users.
The global supply of C3F8 ophthalmic gas faces high technical and compliance barriers. Strict standards govern gas purity, impurity control and aseptic processing, and all major global markets classify it as a high-risk medical device with stringent registration and clinical validation requirements, creating notable market entry barriers. Core production capacity concentrates in developed economies with mature pharmaceutical industries, while local capacity in emerging markets advances toward compliance as regulatory systems improve, resulting in a highly concentrated supply landscape. Fluorinated gas production is subject to global environmental policies, and greenhouse gas emission controls restrict capacity expansion and supply chain layout, driving production shifts to low-carbon processes. On the demand side, demand trends are highly correlated with the global burden of ophthalmic diseases. Population aging, rising myopia prevalence and chronic eye disease prevalence deliver long-term demand support, and the widespread adoption of minimally invasive ophthalmic surgery further lifts product usage frequency. Demand stays stable in mature markets and grows steadily in emerging markets with improved ophthalmic care access. Major global economies keep strengthening full-life-cycle medical device regulation, improve traceability and quality control standards, and tighten emission rules for fluorinated gases, pushing the industry to increase investment in process optimization. Technological iteration and compliance capability become core competitive pillars for market participants.
This report is a detailed and comprehensive analysis for global C3F8 Ophthalmic Gas market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global C3F8 Ophthalmic Gas market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global C3F8 Ophthalmic Gas market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global C3F8 Ophthalmic Gas market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global C3F8 Ophthalmic Gas market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for C3F8 Ophthalmic Gas
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global C3F8 Ophthalmic Gas market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcon, Alchimia, Scott Medical, DORC (ZEISS), Pharmpur, BVI Medical, Fluoron GmbH, Micromed, Shanghai Jesvis Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
C3F8 Ophthalmic Gas market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pure C3F8
Gas Mixture
Market segment by Specification
30 ml/unit
40 ml/unit
Others
Market segment by Application
Hospital
Ophthalmology Clinic
Major players covered
Alcon
Alchimia
Scott Medical
DORC (ZEISS)
Pharmpur
BVI Medical
Fluoron GmbH
Micromed
Shanghai Jesvis Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe C3F8 Ophthalmic Gas product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of C3F8 Ophthalmic Gas, with price, sales quantity, revenue, and global market share of C3F8 Ophthalmic Gas from 2021 to 2026.
Chapter 3, the C3F8 Ophthalmic Gas competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the C3F8 Ophthalmic Gas breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and C3F8 Ophthalmic Gas market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of C3F8 Ophthalmic Gas.
Chapter 14 and 15, to describe C3F8 Ophthalmic Gas sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on C3F8 Ophthalmic Gas. Industry analysis & Market Report on C3F8 Ophthalmic Gas is a syndicated market report, published as Global C3F8 Ophthalmic Gas Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of C3F8 Ophthalmic Gas market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.